Navigation Links
Baxano Rapidly Expands Sales Force to Support Robust Demand for the iO-Flex® System
Date:10/31/2011

SAN JOSE, Calif., Oct. 31, 2011 /PRNewswire/ -- Baxano, Inc., a Silicon Valley based medical device company and manufacturer of the iO-Flex® System for spinal decompression surgery, announces a rapid expansion of its sales infrastructure to meet the surging demand for its products.

This continued expansion in the field infrastructure will help increase Baxano's reach into new and existing accounts throughout the U.S. while providing greater support to surgeons in their efforts to help treat a growing number of patients suffering from lumbar spinal stenosis (LSS), a disease that currently affects roughly 3 million adults annually.

Tony Recupero, President & CEO of Baxano, commented, "We are very optimistic about Baxano's current success and future prospects.  Our monthly sales have grown 300% during the first three quarters of 2011 and Q4 is showing even stronger growth rates.  We are expanding our sales coverage so that we can continue to deliver this very innovative technology to surgeons who are treating LSS patients."

Baxano's flagship iO-Flex® System is the first minimally invasive set of flexible instruments designed to target lumbar stenosis in the central canal, lateral recess and neural foramen, with minimal disruption to the patient's healthy anatomy. It is the only treatment alternative that is able to reach and remove tissue that creates pressure on multiple nerve roots through a single incision.

The Company is also currently enrolling patients in two separate post-market trials (iO-Flex Study and STRiDE) to further demonstrate outcomes and economics relative to traditional treatments for LSS.

About Baxano, Inc.

Baxano, Inc., based in San Jose, California, is a privately held company which was founded in 2005 with the vision to create flexible tools to provide precision lumbar decompression from the "inside out."  These important platform technologies will form the basis for future product offerings.  

Baxano's mission is to develop innovative tools that restore spine function, preserve healthy tissue, and enable a better quality of life for the patients we serve.

Along with our dedication to advanced technology development, Baxano is focused on providing exceptional value to patients, customers, investors and employees. For more information about Baxano and its products, please visit: www.baxano.com

Contact:
Amie Borgstrom
Vice President, Marketing
Phone: 408-514-2217
aborgstrom@baxano.com


'/>"/>
SOURCE Baxano, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Baxano, Inc. Names George A. Harter, Jr. as Chief Financial Officer
2. Baxano, Inc. Awarded Prestigious 2010 Spine Technology Awards
3. Baxano, Inc. Announces Close of $30 Million Series C Funding
4. GNS Healthcare, Inc. Expands Senior Management Team to Leverage the Rapidly Growing Opportunities for Big Data in Healthcare Management
5. Digital Assent Expands Leadership Team to Address Rapidly Growing Demand for the PatientPad
6. Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds
7. Marken Rapidly Responds to Global Supply Chain Security Measures
8. Installation of Next Generation Proton Therapy System Progressing Rapidly
9. endpoint Launches PULSE 2.0 Allowing Clinical Research Teams to Save Additional Time and Money By Rapidly Deploying Studies With Custom Reporting
10. Medco Completes Acquisition of United BioSource Corporation, Creating Powerful Engine for Rapidly Advancing Clinical Insight and Innovation
11. Elekta VMAT Radiation Therapy Rapidly Gaining Users Worldwide as Technique Evolves
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Any dentist who has made ... the current process. Many of them do not even offer ... difficulties and high laboratory costs involved. And those who ARE ... at such a high cost that the majority of today,s ... Dr. Parsa Zadeh , founder of Dental Evolutions Inc. ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the ... in the world, and the most handsome men, look naturally attractive. Plastic surgery ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement ... Vice President of North American Capital Sales at HTG Molecular . ... in the commercialization of the HTG EdgeSeq system and associated reagents in North America. ...
Breaking Medicine News(10 mins):